bluebird bio Announces First Patient Treated with bb2121 in CRB-401 Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma Read more about bluebird bio Announces First Patient Treated with bb2121 in CRB-401 Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma
bluebird bio to Present at the 34th Annual J.P. Morgan Healthcare Conference Read more about bluebird bio to Present at the 34th Annual J.P. Morgan Healthcare Conference
bluebird bio Presents Pre-Clinical and Manufacturing Data from CAR T Oncology Programs at ASH Annual Meeting Read more about bluebird bio Presents Pre-Clinical and Manufacturing Data from CAR T Oncology Programs at ASH Annual Meeting
bluebird bio Reports New Beta-thalassemia Major and Severe Sickle Cell Disease Data from HGB-205 and HGB-206 Studies of LentiGlobin® at ASH Annual Meeting Read more about bluebird bio Reports New Beta-thalassemia Major and Severe Sickle Cell Disease Data from HGB-205 and HGB-206 Studies of LentiGlobin® at ASH Annual Meeting
bluebird bio Reports New Beta-thalassemia Major Data from Northstar Study of LentiGlobin® at ASH Annual Meeting Read more about bluebird bio Reports New Beta-thalassemia Major Data from Northstar Study of LentiGlobin® at ASH Annual Meeting
bluebird bio and ViroMed Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy Read more about bluebird bio and ViroMed Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy
bluebird bio Announces Participation in 27th Annual Piper Jaffray Healthcare Conference Read more about bluebird bio Announces Participation in 27th Annual Piper Jaffray Healthcare Conference
bluebird bio to present LentiGlobin® BB305 Clinical Data and bb2121 Preclinical Data at Annual Meeting of the American Society of Hematology Read more about bluebird bio to present LentiGlobin® BB305 Clinical Data and bb2121 Preclinical Data at Annual Meeting of the American Society of Hematology
bluebird bio Reports Third Quarter 2015 Financial Results and Recent Operational Progress Read more about bluebird bio Reports Third Quarter 2015 Financial Results and Recent Operational Progress
bluebird bio Announces Participation in 24th Annual Credit Suisse Healthcare Conference Read more about bluebird bio Announces Participation in 24th Annual Credit Suisse Healthcare Conference